Skip to main content
Premium Trial:

Request an Annual Quote

ViraCor, IBT to Merge

NEW YORK (GenomeWeb News) – ViraCor Laboratories and IBT Laboratories announced today that they will merge to form a new specialty diagnostic testing lab.

The merger will combine ViraCor's molecular diagnostic testing services with IBT's focus on immunology and allergy testing. Terms of the merger were not disclosed.

"This merger gives ViraCor and IBT the combined scientific know-how and national network not only to reach additional customers who could benefit from our current test menu, but also to expand our services, providing the critical diagnostic information that clinicians need to improve health outcomes for patients," ViraCor President John Martin, who will serve as president of the combined company, said in a statement.

The merged entity will employ more than 200 staffers and will serve more than 4,000 physicians, hospitals, commercial labs, and biopharmaceutical companies, the firms said.

The firm also expects to continue operating out of its two labs, which are located only 22 miles apart in the Kansas City area.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.